REVIEW
Published on 14 Aug 2026
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer’s and Parkinson’s disease
doi 10.3389/fnins.2026.1906426
- 2,259 views
- Frontiers in Endocrinology
- Neuroendocrine Science
- Research Topics
- GLP-1s for Neurodegenerative Disease
GLP-1s for Neurodegenerative Disease
1,558
Total downloads
29k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 13 Aug 2026
Glucagon-like peptide-1 receptor agonists and the risk of Parkinson’s disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data
doi 10.3389/fendo.2026.1849318
- 1,002 views
SYSTEMATIC REVIEW
Published on 03 Jul 2026
GLP-1 receptor agonists in Parkinson’s disease: a meta-analysis revealing motor benefit and highlighting mood improvement
doi 10.3389/fneur.2026.1858507
- 1,683 views
MINI REVIEW
Published on 20 Nov 2025
GLP-1 receptor agonists in Alzheimer’s and Parkinson’s disease: endocrine pathways, clinical evidence, and future directions
doi 10.3389/fendo.2025.1708565
- 8,991 views
- 13 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: